Dr. Busino received his graduate degree at the European Institute of Oncology in Italy and continued his training as post-doctoral fellow at the New York University. Dr. Busino team studies the molecular mechanisms of cell proliferation, specifically how misregulation of Ubiquitin Proteasome System (UPS) contribute to cancer. His current research interest is focused on investigating the functions of novel ubiquitin ligases that are mutated and/or misregulated in hematologic diseases. Alterations of proteins degradation are common events in cancer, thus studying the ubiquitin pathway will provide novel avenues for therapeutics.